Infection, its treatment and the risk for stroke

Current Vascular Pharmacology

Volumn 7, Issue 2, 2009, Pages 146-152

  Palm, Frederick ^a   Urbanek, Christian ^a   Grau, Armin ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Chlamydia pneumoniae; Helicobacter pylori; Infection; Prevention; Stroke

Indexed keywords

ACTIVATED PROTEIN C; INFLUENZA VACCINE; MACROLIDE; ROXITHROMYCIN;

AGE DISTRIBUTION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; ERADICATION THERAPY; HEART INFARCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; INFECTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PATHOPHYSIOLOGY; PERIODONTITIS; RESPIRATORY TRACT INFECTION; REVIEW; RISK REDUCTION; URINARY TRACT INFECTION;

ACUTE DISEASE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFECTION; PERIODONTITIS; RISK FACTORS; STROKE;

EID: 65949083580     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016109787455707     Document Type: Review

References (93)

1. Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psychiat 1996; 61: 333-8.
2. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
3. Silvestrelli G, Parnetti L, Paciaroni M, Caso V, Corea F, Vitali R, et al. Early admission to stroke unit influences clinical outcome. Eur J Neurol 2006; 13: 250-5.
4. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, Donnan G. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 1999; 53: S3-14.
5. Koennecke HC. Secondary prevention of stroke: a practical guide to drug treatment. CNS Drugs 2004; 18: 221-41.
6. Gorelick PB. New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 2002; 1: 149-56.
7. Howard G, Howard VJ, Katholi C, Oli MK, Huston S. Decline in US stroke mortality: an analysis of temporal patterns by sex, race, and geographic region. Stroke 2001; 32: 2213-20.
8. Kelly-Hayes M, Wolf PA, Kase CS, Brand FN, McGuirk JM, D'Agostino RB. Temporal patterns of stroke onset. The Framingham Study. Stroke 1995; 26: 1343-7.
9. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995; 26: 373-9.
10. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-20.
11. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive vs. conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357: 577-81.
12. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998; 98: 839-44.
13. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) 1988; 296: 1156-60.
14. Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke 1996; 27: 2204-6.
15. Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M. Precipitants of brain infarction. Roles of preceding infection/ inflammation and recent psychological stress. Stroke 1996; 27: 1999-2004.
16. Nencini P, Sarti C, Innocenti R, Pracucci G, Inzitari D. Acute inflammatory events and ischemic stroke subtypes. Cerebrovasc Dis 2003; 15: 215-21.
17. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-32.
18. Guillon B, Berthet K, Benslamia L, Bertrand M, Bousser MG, Tzourio C. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke 2003; 34: e79-81.
19. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-8.
20. Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998; 50: 196-203.
21. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/ macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-79.
22. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994; 122: 135-9.
23. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci1996; 137: 69-78.
24. Martinez MA, Pena JM, Fernandez A, Jiménez M, Juárez S, Madero R, et al. Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha. Crit Care Med 1999; 27: 1303-8.
25. Conway EM, Bach R, Rosenberg RD, Konigsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 1989; 53: 231-41.
26. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2007; 83: 536-45.
27. Corcoran PA, Atherton JC, Kerrigan SW, Wadstrom T, Murray FE, Peek RM, et al. The effect of different strains of Helicobacter pylori on platelet aggregation. Can J Gastroenterol 2007; 21: 367-70.
28. Esmon CT, Taylor FB, Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-5.
29. Okajima K, Yang WP, Okabe H, Inoue M, Takatsuki K. Role of leukocytes in the activation of intravascular coagulation in patients with septicemia. Am J Hematol 1991; 36: 265-71.
30. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996; 27: 2005-11.
31. Grau AJ, Buggle F, Steichen-Wiehn C, Heindl S, Banerjee T, Seitz R, et al. Clinical and biochemical analysis in infection-associated stroke. Stroke 1995; 26: 1520-6.
32. Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, et al. Infections and endothelial cells. Cardiovasc Res 2003; 60: 40-8.
33. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-45.
34. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 1981; 113: 30-43.
35. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol 1974; 100: 40-8.
36. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003; 107: 762-8.
37. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513-8.
38. Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005; 36: 1501-6.
39. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-32.
40. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
41. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: S419-20.
42. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
43. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47: 239-43.
44. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65: 168-72.
45. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96: 396-9.
46. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
47. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
48. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161-8.
49. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-61.
50. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14 Suppl K: 62-5.
51. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29: 404-10.
52. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000; 31: 1521-5.
53. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999; 30: 299-305.
54. Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, et al. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. Stroke 1999; 30: 2013-8.
55. Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke 2001; 32: 2253-8.
56. Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR, et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9: 303-6.
57. Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y, et al. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis 2003; 16: 166-70.
58. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27: 2207-10.
59. Apfalter P. Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again? Stroke 2006; 37: 756-8.
60. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158-61.
61. Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000; 181 Suppl 3: S402-10.
62. Maass M, Gieffers J, Krause E, Engel PM, Bartels C, Solbach W. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol 1998; 187: 103-6.
63. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura E, Vitale G, et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006; 37: 482-6.
64. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 2004; 109: 1010-5.
65. Vainas T, Stassen FR, Schurink GW, Tordoir JH, Welten RJ, van den Akker LH, et al. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2005; 29: 403-11.
66. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501.
67. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-7.
68. Fiedorek SC, Malaty HM, Evans DL, Pumphrey CL, Casteel HB, Evans DJ Jr, et al. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 1991; 88: 578-82.
69. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32: 385-91.
70. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999; 99: 852-4.
71. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998; 64: 104-7.
72. Grau AJ, Buggle F, Lichy C, Brandt T, Becher H, Rudi J, et al. Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin. J Neurol Sci 2001; 186: 1-5.
73. Ponzetto A, Marchet A, Pellicano R, Lovera N, Chianale G, Nobili M, et al. Association of Helicobacter pylori infection with ischemic stroke of non-cardiac origin: the BAT.MA.N. project study. Hepatogastroenterology 2002; 49: 631-4.
74. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996; 75: 568-72.
75. Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, et al. Cytotoxin-associated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002; 106: 580-4.
76. Preusch MR, Grau AJ, Buggle F, Lichy C, Bartel J, Black C, et al. Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 2004; 35: 1800-4.
77. Borrell LN, Burt BA, Taylor GW. Prevalence and trends in periodontitis in the USA: the corrected NHANES, 1988 to 2000. J Dent Res 2005; 84: 924-30.
78. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138: S534-6.
79. Li L, Messas E, Batista EL Jr., Leyine RA, Amor S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105: 861-7.
80. Grau AJ. Infection, inflammation, and cerebrovascular ischemia. Neurology 1997; 49: S47-51.
81. Syrjanen J, Peltola J, Valtonen V, Iivanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med 1989; 225: 179-84.
82. Grau AJ, Becher H, Ziegler CM, Lichy C, Buggle F, Kaiser C. Periodontal disease as a risk factor for ischemic stroke. Stroke 2004; 35: 496-501.
83. Desvarieux M, Schwahn C, Volzke H, Demmer RT, Lüdemann J, Kessler C, et al. Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke 2004; 35: 2029-35.
84. Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, Knekt P. Antibodies to periodontal pathogens and stroke risk. Stroke 2004; 35: 2020-3.
85. Pussinen PJ, Alfthan G, Jousilahti P, Paju S, Tuomilent OJ. Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 2007; 193: 222-8.
86. D'Aiuto F, Parkar M, Andreou G, Suvan T, Brett PM, Ready D, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156-60.
87. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84: 269-73.
88. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006; 151: 977-84.
89. Paju S, Pussinen PJ, Sinisalo J, Mattila K, Dogan B, Ahlberg J, et al. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. Atherosclerosis 2006; 188: 412-9.
90. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: e20-8.
91. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-6.
92. Ngeh J, Goodbourn C. Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease. Stroke 2005; 36: 259-65.
93. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064-70.